Literature DB >> 978496

The magnitude and duration of respiratory depression produced by fentanyl and fentanyl plus droperidol in man.

M H Harper, R F Hickey, T H Cromwell, S Linwood.   

Abstract

In 10 healthy male volunteers breathing 100% oxygen, we determined the effect of four intravenous dose levels of fentanyl (0.0015, 0.003, 0.006 and 0.009 mg/kg) and two of fentanyl plus droperidol (i.e., Innovar, 0.003 and 0.006 mg/kg of fentanyl with 2.5 mg of droperidol for each 0.05 mg of fentanyl) on PECO2 and the slope of the ventilatory response to imposed increases in PECO2. All doses of fentanyl and fentanyl plus droperidol depressed the slope and shifted the curve to the right. Depression was dose related and was maximum 5 minutes after administration. The slope returned to control by 2 hours postinjection even at the highest narcotic dose. However, the rightward shift of the CO2 response curve require 4 hours to return to control. Droperidol added to fentanyl did not increase or prolong the respiratory depression seen with fentanyl alone at equivalent dose levels. Nausea and emesis occurred more frequently with fentanyl alone and orthostatic hypotension occurred more frequently with droperidol plus fentanyl. Dysphoria was a prominent consequence of fentanyl plus droperidol administration.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 978496

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  12 in total

Review 1.  Intravenous droperidol: a review of its use in the management of postoperative nausea and vomiting.

Authors:  Kate McKeage; Dene Simpson; Antona J Wagstaff
Journal:  Drugs       Date:  2006       Impact factor: 9.546

2.  Anesthesiology-epitomes of progress: is fentanyl a wonder drug?

Authors:  J H Eisele
Journal:  West J Med       Date:  1978-02

3.  Delayed respiratory depression with fentanyl.

Authors:  J Smydo
Journal:  Anesth Prog       Date:  1979 Mar-Apr

4.  Monoclonal Antibodies for Combating Synthetic Opioid Intoxication.

Authors:  Lauren C Smith; Paul T Bremer; Candy S Hwang; Bin Zhou; Beverly Ellis; Mark S Hixon; Kim D Janda
Journal:  J Am Chem Soc       Date:  2019-06-25       Impact factor: 15.419

5.  Psychomotor, respiratory and neuroendocrinological effects of nalbuphine and haloperidol, alone and in combination, in healthy subjects.

Authors:  U Saarialho-Kere
Journal:  Br J Clin Pharmacol       Date:  1988-07       Impact factor: 4.335

6.  Premedication for fibreoptic bronchoscopy: fentanyl, diazepam, and atropine compared with papaveretum and hyoscine.

Authors:  T Goroszeniuk; I H Nicholas; P Marchant; J A Turner; N M Johnson
Journal:  Br Med J       Date:  1980-08-16

Review 7.  Clinical pharmacokinetics of fentanyl and its newer derivatives.

Authors:  L E Mather
Journal:  Clin Pharmacokinet       Date:  1983 Sep-Oct       Impact factor: 6.447

8.  A comparison of fentanyl, esmolol, and their combination for blunting the haemodynamic responses during rapid-sequence induction.

Authors:  K S Chung; R S Sinatra; J D Halevy; D Paige; D G Silverman
Journal:  Can J Anaesth       Date:  1992-10       Impact factor: 5.063

9.  Pharmacodynamics of fentanyl citrate in patients undergoing aortocoronary bypass.

Authors:  Adolph J Koska; Alexander Romagnoli; William G. Kramer
Journal:  Cardiovasc Dis       Date:  1981-09

10.  Early extubation after high-dose fentanyl anaesthesia for aortocoronary bypass surgery: reversal of respiratory depression with low-dose nalbuphine.

Authors:  J G Ramsay; B D Higgs; J E Wynands; R Robbins; G E Townsend
Journal:  Can Anaesth Soc J       Date:  1985-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.